News Focus
News Focus
icon url

Pharmacydude

03/06/22 2:44 PM

#372375 RE: Whalatane #372368

Kiwi
“they “don’t believe in preventative cardiology” according to Bhatt,



Please provide a link to that comment to verify “

It was a video call between Dr Bhatt and myself, nobody else, no witnesses. There is no link. I wish I had recorded it but I didn’t think of it at the time. We talked about a lot of topics. He said he was the one that got KP to do the MITIGATE trial because they had the data to make it happen quickly and inexpensively. I asked why they couldn’t just mine their existing data for V Pts and see if there was a lower incidence of COVID. He replied they don’t have many Pts on V so I asked why? He said “they don’t believe in preventative cardiology I GUESS”. I left out the last 2 words and I’m going from memory from last June. Later I asked “shouldn’t all the control subjects be on V anyway?” To which he replied:” I suppose that’s true, (paused) like I said, they don’t believe in preventative cardiology”. The clear impression I got from him was that he was not a fan of KP.
Kiwi - how many 100,000’s of secondary prevention Pts does KP care for in their systems? Why aren’t they calling/texting these Pts to come in and get V??? If they did there would be a noticeable spike in V Rx in California.
Prevention means money up front for possible benefits in the future. Businesses (private/nonprofit/government) tend to be too focused on containing costs THIS QUARTER to think 5 years down the road for preventing an MI. Decision makers have to be on budget this quarter to get their bonus this quarter. Saving money from the hospital MI treatment budget does result in the drug expenses budget get more funds to cover for the 5 years of V. Different department different budget